Pharmaphorum is an online publication on a mission to educate, inform, engage, and connect pharmaceutical industry leaders and to equip them to thrive in healthcare’s evolving digital future. Pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in

  • 328articles · 90d
  • 1+ day agolatest article
  • Jun 15, 2026earliest in window
  • 66%with images
  • 360avg words
articles per day
Categories
  • Medical 250
  • Health & Wellness 226
  • Health 163
  • Economy, Business & Finance 115
  • Business & Industrial 88
  • Finance & Business 54
  • Science & Technology 36
  • Science & Nature 16

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

pharmaphorum
pharmaphorum.com > news > eu-first-clear-abbvies-rinvoq-alopecia-areata

EU first to clear AbbVie's Rinvoq for alopecia areata

1+ mon, 2+ week ago   (415+ words) AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, the first market for the hair loss disorder, adding to a lengthening list of approved indications for the blockbuster brand. The green light from the European…...